Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

977 An ICOS–IFN-γ T-cell signature links CNS immune-related adverse events and immune-mediated hepatitis following dual CTLA-4/PD-1 blockade

  • Max Levin1
  • Anna Rudin2
  • Anna-Carin Lundell3
  • Sara Bjursten4
  • Lars Ny5
  • Hervé Luche6
  • Sukanya Raghavan7
  • Hifaa Al Remawi3
  • Timothy Sundell3
  • Maria Lindén3
  • Maelle-Marine Monier8
8 affiliations
  1. 1Department of Oncology, Sahlgrenska University Hospital, Goteborg, Sweden
  2. 2Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
  3. 3University of Gothenburg, Gothenburg, Västra Götaland, Sweden
  4. 4Department of Oncology, Institute of Clinical Sciences, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden
  5. 5Sahlgrenska University Hospital, Gothenburg, Västra Götaland, Sweden
  6. 62CIPHE, Marseille, France
  7. 71University of Gothenburg, Gothenburg, Sweden
  8. 8Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Västra Götaland, Sweden
Open at sourcePDFDOICite

Related

  1. Endocannabinoid-mediated rescue of somatosensory cortex activity, plasticity and related behaviors following an early-life concussion in male mice
    Jérôme BADAUT, Lea HIPPAUF, Mathilde MALINCONI +3
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textNeuroscienceGeneral medicineNatureCrossrefHAL
  2. Reply to ‘DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?’
    Daryl T-Y Lau, Ying-Hsiu Su, Haitao Guo
    GutPeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
  3. Autoimmune hepatitis following long-term denosumab therapy in a patient with Hashimoto thyroiditis
    JCEM case reportsPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  4. Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
    S. Leo, I. Dhoparee-Doomah, S. Negi +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. Prevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia
    Annabelle Stevens, Anna Conway, Nigel Carrington +10
    Liver international : official journal of the International Association for the Study of the LiverPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{levin2026icosifnγ,
  title = {{977 An ICOS–IFN-γ T-cell signature links CNS immune-related adverse events and immune-mediated hepatitis following dual CTLA-4/PD-1 blockade}},
  author = {Max Levin and Anna Rudin and Anna-Carin Lundell and Sara Bjursten and Lars Ny and Hervé Luche and Sukanya Raghavan and Hifaa Al Remawi and Timothy Sundell and Maria Lindén and Maelle-Marine Monier},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0977},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0977},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 977 An ICOS–IFN-γ T-cell signature links CNS immune-related adverse events and immune-mediated hepatitis following dual CTLA-4/PD-1 blockade
AU  - Max Levin
AU  - Anna Rudin
AU  - Anna-Carin Lundell
AU  - Sara Bjursten
AU  - Lars Ny
AU  - Hervé Luche
AU  - Sukanya Raghavan
AU  - Hifaa Al Remawi
AU  - Timothy Sundell
AU  - Maria Lindén
AU  - Maelle-Marine Monier
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0977
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0977
SN  - 2051-1426
ER  -